Zymeworks (ZYME) Share-based Compensation (2021 - 2026)

Zymeworks has reported Share-based Compensation for 6 years, with the latest figure at $6.9 million in Q1 2026.

• Quarterly Share-based Compensation rose 806.54% year-over-year to $6.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $34.2 million (up 4371.11% YoY) and the FY2025 annual result came in at $28.0 million, changed N/A from the prior year.
• Share-based Compensation eased to $6.9 million in Q1 2026 per ZYME's latest filing, from $8.8 million in the prior quarter.
• Over five years, Share-based Compensation peaked at $11.5 million in Q2 2025 and troughed at -$8.1 million in Q3 2024.
• A 5-year average of $2.3 million and a median of $2.0 million in 2023 frame the typical range for Share-based Compensation.
• The widest YoY moves for Share-based Compensation: up 3129.17% in 2023, down 952.61% in 2023.
• Over 5 years, Share-based Compensation stood at $555000.0 in 2022, then slumped by 952.61% to -$4.7 million in 2023, then plunged by 71.32% to -$8.1 million in 2024, then soared by 209.16% to $8.8 million in 2025, then fell by 21.64% to $6.9 million in 2026.
• According to Business Quant data, Share-based Compensation over the past three periods registered $6.9 million, $8.8 million, and $6.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.